Sleep disorder device manufacturer Oventus has completed its A$9.3m (US$6.5m) capital raise on the ASX with an oversubscribed A$2.3m entitlement offer. It previously raised A$7m in a two tranche placement….
Sleep disorder device manufacturer Oventus has completed its A$9.3m (US$6.5m) capital raise on the ASX with an oversubscribed A$2.3m entitlement offer. It previously raised A$7m in a two tranche placement….
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference